Journal ArticleOPEN ACCESS

Human stem cell-derived cardiomyocytes for pharmacological and toxicological modeling

Annals of the New York Academy of Sciences (2011) 1245(1) 48-49
DOI: 10.1111/j.1749-6632.2011.06328.x
4Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

Abstract

Cardiomyocytes derived from human pluripotent stem cells have advantages for modeling in terms of phenotype, longevity in culture, ease of transfection, and high-throughput capability. © 2011 New York Academy of Sciences.

Author supplied keywords

Cite

CITATION STYLE

APA

Harding, S. E. (2011). Human stem cell-derived cardiomyocytes for pharmacological and toxicological modeling. Annals of the New York Academy of Sciences, 1245(1), 48–49. https://doi.org/10.1111/j.1749-6632.2011.06328.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free